1. Home
  2. HLMN vs PHVS Comparison

HLMN vs PHVS Comparison

Compare HLMN & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$8.06

Market Cap

1.6B

ML Signal

HOLD

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$25.40

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
PHVS
Founded
1964
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
HLMN
PHVS
Price
$8.06
$25.40
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$11.60
$40.70
AVG Volume (30 Days)
1.9M
102.7K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
122.22
N/A
EPS
0.20
N/A
Revenue
$1,552,224,000.00
N/A
Revenue This Year
$7.65
N/A
Revenue Next Year
$4.79
N/A
P/E Ratio
$40.15
N/A
Revenue Growth
5.41
N/A
52 Week Low
$6.63
$11.51
52 Week High
$10.85
$29.80

Technical Indicators

Market Signals
Indicator
HLMN
PHVS
Relative Strength Index (RSI) 35.18 41.76
Support Level $7.91 $24.25
Resistance Level $8.32 $26.11
Average True Range (ATR) 0.24 1.12
MACD -0.01 -0.19
Stochastic Oscillator 22.84 9.24

Price Performance

Historical Comparison
HLMN
PHVS

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: